Abstract
Recent technological advances in studying proteins using mass spectrometry (MS-based proteomics) have empowered in-depth profiling of the human proteome, such that MS-based proteomics can nowadays identify disease-specific proteins indicative of a particular cancer, and highlight molecular pathways associated with both sensitivity and resistance to drugs. However, in order to obtain
... read more